Document Detail

Treatment of retinal arterial occlusion.
MedLine Citation:
PMID:  6161328     Owner:  NLM     Status:  MEDLINE    
The various possibilities of treating arterial retinal occlusions are reviewed. Although thrombolysis is regarded today as the most dependable therapeutic method it has the most contraindications and carries the highest risk. There are less contraindications to anticoagulative treatment. The results are, however, not as good as with thrombolysis. The action of vasodilators is only positive if an intensive general cardiovascular treatment also take place. Attempts to influence the viscosity of blood via xanthine derivatives (also to increase glucose metabolism) appear promising as do the antithrombocyte aggregation action of acetylsalicylic acid. Low molecular dextran solutions (plasma expanders) have also been used with success although these also demand a general stabilization of the circulation.
H Rossmann
Related Documents :
25426238 - Endovascular management of ureteroarterial fistula: a rare potentially life threatening...
21113368 - Posterior atlantoaxial screw-rod fixation in a case of aberrant vertebral artery course...
2189158 - Vasculitis in behçet's disease.
207248 - Central retinal artery occlusion complicating fabry's disease.
11235738 - Late-onset dysphagia lusoria.
25192408 - Ross procedure in a child with aspergillus endocarditis and bicuspid aortic valve.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde     Volume:  180     ISSN:  0030-3755     ISO Abbreviation:  Ophthalmologica     Publication Date:  1980  
Date Detail:
Created Date:  1981-03-24     Completed Date:  1981-03-24     Revised Date:  2007-09-17    
Medline Journal Info:
Nlm Unique ID:  0054655     Medline TA:  Ophthalmologica     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  68-74     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenal Cortex Hormones / therapeutic use
Anticoagulants / therapeutic use
Arteriosclerosis / drug therapy
Dextrans / therapeutic use
Fibrinolytic Agents / therapeutic use
Platelet Aggregation / drug effects
Retinal Artery* / radiography
Thrombosis / diagnosis,  drug therapy*
Vasodilator Agents / therapeutic use
Reg. No./Substance:
0/Adrenal Cortex Hormones; 0/Anticoagulants; 0/Fibrinolytic Agents; 0/Vasodilator Agents; 9004-54-0/Dextrans

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Traumatic arteriovenous malformation of the eyelid.
Next Document:  Current techniques in chromosome analysis.